OFI Invest Asset Management
RDY icon

OFI Invest Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

OFI Invest Asset Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-40,000
Closed -$455K – 138
2023
Q1 		$455K Buy
+40,000
New +$432K 0.02% 97

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OFI Invest Asset Management's RDY Position: Q2 2023 in Review

OFI Invest Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2023, closing a stake of 40,000 shares — an estimated $455K sold.

OFI Invest Asset Management first reported a position in RDY in Q1 2023 and held it in 1 quarter. The position peaked at $455K in Q1 2023. 194 funds tracked by Wall St. Rank hold RDY as of Q2 2023.

  • OFI Invest Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2023 after selling out during the quarter.
  • OFI Invest Asset Management sold 40,000 Dr. Reddy's Laboratories shares in Q2 2023, an estimated $455K.
  • OFI Invest Asset Management first reported a position in Dr. Reddy's Laboratories in Q1 2023 and held it in 1 quarter.
  • OFI Invest Asset Management's Dr. Reddy's Laboratories position peaked at $455K in Q1 2023.
  • 194 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2023.

Based on OFI Invest Asset Management's 13F filing for Q2 2023, filed 31 Jul 2023.